Literature DB >> 7286040

Impaired cimetidine absorption due to antacids and metoclopramide.

R Gugler, M Brand, A Somogyi.   

Abstract

In 8 healthy subjects the absorption of cimetidine was investigated when given alone, together with 60 ml aluminium/magnesium hydroxide containing antacid (neutralising capacity 26 mmol HCl/10 ml), and together with liquid metoclopramide 14 mg. The antacid significantly (P less than 0.01) reduced the bioavailability (area under the plasma level-time curve) of cimetidine, on average by one third. Metoclopramide also reduced the bioavailability by an average of 22%. The reductions were associated with significantly reduced excretion of cimetidine in urine. There was no change in the half-life or renal clearance of cimetidine, supporting the hypothesis of reduced gastrointestinal absorption. The results indicate that cimetidine and antacids should not be given together, and that the dose of cimetidine may have to be increased if it is administered concomitantly with metoclopramide.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7286040     DOI: 10.1007/BF00544602

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  Prediction of digoxin dose requirements.

Authors:  S M Dobbs; G E Mawer
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

2.  Effects of antacids on gastric emptying.

Authors:  A Hurwitz; R G Robinson; T S Vats; F C Whittier; W F Herrin
Journal:  Gastroenterology       Date:  1976-08       Impact factor: 22.682

3.  Effect of cimetidine on serum gastrin and gastric emptying in man.

Authors:  R F Logan; J A Forrest; G P McLoughlin; G Lidgard; R C Heading
Journal:  Digestion       Date:  1978       Impact factor: 3.216

4.  Diminished absorption of cimetidine caused by antacids.

Authors:  G Bodemar; B Norlander; A Walan
Journal:  Lancet       Date:  1979-02-24       Impact factor: 79.321

Review 5.  Drugs, diseases and altered gastric emptying.

Authors:  W S Nimmo
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

6.  Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients.

Authors:  A Somogyi; H G Rohner; R Gugler
Journal:  Clin Pharmacokinet       Date:  1980 Jan-Feb       Impact factor: 6.447

7.  Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level--time curve.

Authors:  W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

8.  In vitro adsorption studies of cimetidine.

Authors:  F Ganjian; A J Cutie; T Jochsberger
Journal:  J Pharm Sci       Date:  1980-03       Impact factor: 3.534

9.  Effect of metoclopramide on gastric function in man.

Authors:  A M Connell; J D George
Journal:  Gut       Date:  1969-08       Impact factor: 23.059

10.  Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial.

Authors:  J Behar; D L Brand; F C Brown; D O Castell; S Cohen; R J Crossley; C E Pope; C S Winans
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

View more
  26 in total

Review 1.  Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.

Authors:  J H Lin
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

2.  Lack of effect of multiple dose sucralfate on the pharmacokinetics of of roxatidine acetate.

Authors:  M Seibert-Grafe; A Pidgen
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

4.  Effects on cimetidine bioavailability of metoclopramide and antacids given two hours apart.

Authors:  N Barzaghi; F Crema; G Mescoli; E Perucca
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Randomised, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer.

Authors:  J Plas
Journal:  Gut       Date:  1990-04       Impact factor: 23.059

6.  The effect of antacids and metoclopramide on omeprazole absorption and disposition.

Authors:  C W Howden; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1988-06       Impact factor: 4.335

Review 7.  Interaction of roxatidine acetate with antacids, food and other drugs.

Authors:  R A Labs
Journal:  Drugs       Date:  1988       Impact factor: 9.546

8.  Gastric pH influences the appearance of double peaks in the plasma concentration-time profiles of cimetidine after oral administration in dogs.

Authors:  V Mummaneni; G L Amidon; J B Dressman
Journal:  Pharm Res       Date:  1995-05       Impact factor: 4.200

9.  Effect of aluminium phosphate on the bioavailability of cimetidine and prednisolone.

Authors:  H Albin; G Vincon; F Demotes-Mainard; B Begaud; A Bedjaoui
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 10.  Clinical pharmacokinetics of cimetidine.

Authors:  A Somogyi; R Gugler
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.